USANA Health Sciences Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +20.7% | +11.2% | +10.3% | +6.8% | -6.8% | +24.0% | -9.9% | +3.3% | +6.1% | +18.2% | -0.7% | |
| – | +27.9% | +13.8% | +22.4% | +15.3% | -16.5% | +29.2% | -14.3% | +5.1% | +9.6% | -33.2% | +3.3% | |
| – | +28.9% | +22.7% | +40.6% | -13.3% | +9.6% | +33.2% | -23.3% | +20.3% | +14.6% | -45.0% | -12.9% | |
| – | +28.9% | +22.7% | +40.6% | +12.4% | -15.5% | +33.2% | -23.3% | +20.3% | +14.6% | -45.0% | -12.9% | |
| – | -8.5% | +44.6% | -21.0% | +4.3% | -37.6% | -15.3% | -3.5% | +0.7% | -0.2% | +14.2% | – | |
| – | +46.1% | -2.0% | -2.9% | +30.2% | -15.9% | +30.9% | +9.0% | -31.8% | -8.4% | +13.5% | +47.1% | |
| – | +23.6% | +15.1% | +1.6% | -10.5% | +3.5% | +5.5% | +1.3% | +9.7% | – | – | – | |
| – | -2.8% | -4.1% | +4.2% | -3.5% | -1.1% | +4.4% | +1.7% | -1.7% | -1.5% | +743.0% | -4.3% | |
| – | -6.6% | -10.2% | +2.3% | -9.5% | -6.2% | +3.2% | -1.1% | +6.5% | -7.7% | +407.4% | -12.3% | |
| – | +18.2% | +2.1% | +7.4% | +4.7% | +1.2% | +20.6% | -8.3% | -11.2% | -16.4% | +19.4% | -3.2% | |
| – | +20.9% | +5.4% | +1.9% | +5.3% | -8.5% | +23.5% | -4.3% | -10.5% | -17.4% | +17.5% | -7.9% | |
| – | +12.2% | +21.7% | -20.8% | +22.2% | -59.9% | +3.5% | -17.8% | -2.7% | +17.0% | +259.8% | -51.7% | |
| – | +29.1% | -10.0% | +30.4% | -15.6% | +25.9% | +45.3% | -25.8% | -18.2% | -8.9% | +19.0% | +44.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +22.0% | +15.8% | +11.7% | +7.7% | -10.1% | +25.6% | -10.5% | +10.0% | +14.4% | +7.0% | +0.2% | |
| – | +29.1% | +23.5% | +8.5% | +14.4% | -7.1% | +25.0% | -10.0% | +13.6% | +13.7% | +7.6% | -2.8% | |
| – | -3.7% | -5.0% | -1.4% | -0.3% | -7.4% | -6.8% | -4.3% | -5.1% | +0.2% | -0.9% | -3.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.